메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Little is known about the benefits of statin use on liver cancer mortality among patients with chronic hepatitis B (CHB) consideringhypercholesterolemia and obesity. A nationwide retrospective cohort study was conducted using data from a Health ExaminationCohort of the National Health Insurance Service of Korea. Data on CHB patients with no other concurrent liver diseasewere acquired, and statin use was defined as a cumulative daily dose ≥28. A 3-year landmark analysis was performed to avoid immortaltime bias. Patients who started statin therapy within the landmark date were considered statin users. A Cox regressionanalysis was applied to assess associations between statin use and liver cancer mortality considering hypercholesterolemia andobesity. Among 13063 patients, 193 (1.5%) died of liver cancer during the mean follow-up period of 10.6 years. After adjusting fordemographic and metabolic factors, statin use [hazard ratio (HR), 0.17; 95% confidence interval (CI), 0.04–0.70] and hypercholesterolemia(HR, 0.46; 95% CI, 0.24–0.88 for total cholesterol ≥240 mg/dL) were associated with a decreased risk of liver cancer mortality,whereas body mass index (BMI) ≥30 kg/m2 was associated with an increased risk of liver cancer mortality (HR, 2.46; 95% CI,1.20–5.06). This study showed that statin use was associated with decreased liver cancer mortality when adjusting for cholesterollevels and BMI. This study found that hypercholesterolemia was independently associated with decreased liver cancer mortalityregardless of statin use.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0